Calton & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6M | Sell |
6,542
-453
| -6% | -$106K | 0.23% | 89 |
|
|
2025
Q4 | $1.45M | Buy |
6,995
+410
| +6% | +$81.1K | 0.21% | 95 |
|
|
2025
Q3 | $1.22M | Sell |
6,585
-350
| -5% | -$60K | 0.18% | 102 |
|
|
2025
Q2 | $1.06M | Buy |
6,935
+1,396
| +25% | +$215K | 0.18% | 99 |
|
|
2025
Q1 | $919K | Buy |
5,539
+2,074
| +60% | +$325K | 0.21% | 96 |
|
|
2024
Q4 | $501K | Sell |
3,465
-3,002
| -46% | -$465K | 0.22% | 102 |
|
|
2024
Q3 | $1.05M | Buy |
6,467
+751
| +13% | +$120K | 0.4% | 57 |
|
|
2024
Q2 | $835K | Buy |
5,716
+2,597
| +83% | +$386K | 0.42% | 63 |
|
|
2024
Q1 | $493K | Sell |
3,119
-911
| -23% | -$145K | 0.24% | 95 |
|
|
2023
Q4 | $632K | Buy |
4,030
+1,682
| +72% | +$258K | 0.25% | 93 |
|
|
2023
Q3 | $366K | Sell |
2,348
-1,813
| -44% | -$299K | 0.53% | 50 |
|
|
2023
Q2 | $689K | Buy |
4,161
+57
| +1% | +$9.2K | 0.32% | 77 |
|
|
2023
Q1 | $636K | Sell |
4,104
-1,292
| -24% | -$209K | 0.3% | 83 |
|
|
2022
Q4 | $953K | Buy |
5,396
+1,112
| +26% | +$192K | 0.37% | 70 |
|
|
2022
Q3 | $699K | Sell |
4,284
-54
| -1% | -$9.14K | 0.4% | 63 |
|
|
2022
Q2 | $770K | Sell |
4,338
-1,010
| -19% | -$180K | 0.43% | 60 |
|
|
2022
Q1 | $947K | Sell |
5,348
-190
| -3% | -$32.3K | 0.28% | 93 |
|
|
2021
Q4 | $947K | Sell |
5,538
-1,682
| -23% | -$275K | 0.25% | 106 |
|
|
2021
Q3 | $1.17M | Sell |
7,220
-723
| -9% | -$123K | 0.26% | 102 |
|
|
2021
Q2 | $1.31M | Sell |
7,943
-403
| -5% | -$66.7K | 0.25% | 85 |
|
|
2021
Q1 | $1.37M | Sell |
8,346
-1,718
| -17% | -$278K | 0.27% | 74 |
|
|
2020
Q4 | $1.58M | Sell |
10,064
-994
| -9% | -$147K | 0.28% | 68 |
|
|
2020
Q3 | $1.65M | Sell |
11,058
-715
| -6% | -$106K | 0.34% | 61 |
|
|
2020
Q2 | $1.66M | Sell |
11,773
-1,602
| -12% | -$233K | 0.36% | 59 |
|
|
2020
Q1 | $1.75M | Buy |
13,375
+910
| +7% | +$129K | 0.43% | 51 |
|
|
2019
Q4 | $1.82M | Buy |
12,465
+1,959
| +19% | +$266K | 0.37% | 58 |
|
|
2019
Q3 | $1.36M | Buy |
10,506
+202
| +2% | +$26.6K | 0.3% | 64 |
|
|
2019
Q2 | $1.44M | Sell |
10,304
-323
| -3% | -$44.7K | 0.41% | 47 |
|
|
2019
Q1 | $1.49M | Sell |
10,627
-641
| -6% | -$85.9K | 0.45% | 44 |
|
|
2018
Q4 | $1.45M | Buy |
11,268
+22
| +0.2% | +$3.07K | 0.53% | 36 |
|
|
2018
Q3 | $1.55M | Buy |
11,246
+103
| +0.9% | +$13.7K | 0.46% | 35 |
|
|
2018
Q2 | $1.46M | Sell |
11,143
-2,581
| -19% | -$322K | 0.43% | 38 |
|
|
2018
Q1 | $1.76M | Sell |
13,724
-234
| -2% | -$31.6K | 0.51% | 35 |
|
|
2017
Q4 | $1.98M | Buy |
+13,958
| New | +$1.94M | 0.5% | 31 |
|
Other funds holding JNJ
VCM
VPM
Calton & Associates's JNJ Position: Q1 2026 in Review
Calton & Associates reduced its Johnson & Johnson (JNJ) stake by 6.5% in Q1 2026, selling an estimated $106K and leaving 6,542 shares worth $1.6M. The position accounts for 0.23% of the portfolio, ranked #89.
Calton & Associates first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.98M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Calton & Associates held 6,542 shares of Johnson & Johnson worth $1.6M as of Q1 2026.
- Calton & Associates sold 453 Johnson & Johnson shares in Q1 2026, an estimated $106K.
- Johnson & Johnson made up 0.23% of Calton & Associates's portfolio in Q1 2026, its #89 holding.
- Calton & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Calton & Associates's Johnson & Johnson position peaked at $1.98M in Q4 2017.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.